T2Biosystems: The Emerging Leader Developing Innovative Diagnostic Products To Help Save Patient Lives And Reduce Medical Costs

June 23, 2022 8:55 AM | 20 seconds read | Make a Comment

John Sperzal, President and CEO of T2 Biosystems TTOO, was a guest speaker at Benzinga’s All Access on June 17th, 2022. 

T2 Biosystems is an emerging leader in the field of in vitro diagnostics. They’re developed a number of products and medical instruments to help save lives and reduce costs. 

Watch the full interview here

Feature photo

Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: BiotechPenny StocksHealth CareGeneralBenzinga All AccessT2 Biosystems
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!